Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12534353rdf:typepubmed:Citationlld:pubmed
pubmed-article:12534353lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12534353lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:12534353lifeskim:mentionsumls-concept:C0203669lld:lifeskim
pubmed-article:12534353lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:12534353lifeskim:mentionsumls-concept:C1337013lld:lifeskim
pubmed-article:12534353lifeskim:mentionsumls-concept:C0040160lld:lifeskim
pubmed-article:12534353lifeskim:mentionsumls-concept:C0040123lld:lifeskim
pubmed-article:12534353lifeskim:mentionsumls-concept:C1522577lld:lifeskim
pubmed-article:12534353lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:12534353pubmed:issue1lld:pubmed
pubmed-article:12534353pubmed:dateCreated2003-1-21lld:pubmed
pubmed-article:12534353pubmed:abstractTextThe 'standard' postoperative follow-up of patients with differentiated thyroid cancer (DTC) has been based upon serum thyroglobulin (Tg) measurement and (131)I whole body scan ((131)I-WBS) after thyroid hormone (T(4)) treatment withdrawal. However, (131)I-WBS sensitivity has been reported to be low. Thyroid hormone withdrawal, often associated with hypothyroidism-related side effects, may now be replaced by recombinant human thyroid stimulating hormone (rhTSH). The aim of our study was to evaluate the diagnostic accuracy of (131)I-WBS and serum Tg measurement obtained after rhTSH stimulation and of neck ultrasonography in the first follow-up of DTC patients.lld:pubmed
pubmed-article:12534353pubmed:languageenglld:pubmed
pubmed-article:12534353pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12534353pubmed:citationSubsetIMlld:pubmed
pubmed-article:12534353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12534353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12534353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12534353pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12534353pubmed:statusMEDLINElld:pubmed
pubmed-article:12534353pubmed:monthJanlld:pubmed
pubmed-article:12534353pubmed:issn0804-4643lld:pubmed
pubmed-article:12534353pubmed:authorpubmed-author:TrischittaVin...lld:pubmed
pubmed-article:12534353pubmed:authorpubmed-author:Di...lld:pubmed
pubmed-article:12534353pubmed:authorpubmed-author:FilettiSebast...lld:pubmed
pubmed-article:12534353pubmed:authorpubmed-author:SchlumbergerM...lld:pubmed
pubmed-article:12534353pubmed:authorpubmed-author:BiscegliaMich...lld:pubmed
pubmed-article:12534353pubmed:authorpubmed-author:ModoniSergioSlld:pubmed
pubmed-article:12534353pubmed:authorpubmed-author:TorlontanoMas...lld:pubmed
pubmed-article:12534353pubmed:authorpubmed-author:CrocettiUmber...lld:pubmed
pubmed-article:12534353pubmed:authorpubmed-author:D'AloisoLeona...lld:pubmed
pubmed-article:12534353pubmed:authorpubmed-author:BonfittoNazar...lld:pubmed
pubmed-article:12534353pubmed:authorpubmed-author:ValleGuidoGlld:pubmed
pubmed-article:12534353pubmed:authorpubmed-author:FruscianteVin...lld:pubmed
pubmed-article:12534353pubmed:issnTypePrintlld:pubmed
pubmed-article:12534353pubmed:volume148lld:pubmed
pubmed-article:12534353pubmed:ownerNLMlld:pubmed
pubmed-article:12534353pubmed:authorsCompleteYlld:pubmed
pubmed-article:12534353pubmed:pagination19-24lld:pubmed
pubmed-article:12534353pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:12534353pubmed:meshHeadingpubmed-meshheading:12534353...lld:pubmed
pubmed-article:12534353pubmed:meshHeadingpubmed-meshheading:12534353...lld:pubmed
pubmed-article:12534353pubmed:meshHeadingpubmed-meshheading:12534353...lld:pubmed
pubmed-article:12534353pubmed:meshHeadingpubmed-meshheading:12534353...lld:pubmed
pubmed-article:12534353pubmed:meshHeadingpubmed-meshheading:12534353...lld:pubmed
pubmed-article:12534353pubmed:meshHeadingpubmed-meshheading:12534353...lld:pubmed
pubmed-article:12534353pubmed:meshHeadingpubmed-meshheading:12534353...lld:pubmed
pubmed-article:12534353pubmed:meshHeadingpubmed-meshheading:12534353...lld:pubmed
pubmed-article:12534353pubmed:meshHeadingpubmed-meshheading:12534353...lld:pubmed
pubmed-article:12534353pubmed:meshHeadingpubmed-meshheading:12534353...lld:pubmed
pubmed-article:12534353pubmed:meshHeadingpubmed-meshheading:12534353...lld:pubmed
pubmed-article:12534353pubmed:meshHeadingpubmed-meshheading:12534353...lld:pubmed
pubmed-article:12534353pubmed:meshHeadingpubmed-meshheading:12534353...lld:pubmed
pubmed-article:12534353pubmed:meshHeadingpubmed-meshheading:12534353...lld:pubmed
pubmed-article:12534353pubmed:year2003lld:pubmed
pubmed-article:12534353pubmed:articleTitleSerum thyroglobulin and 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer.lld:pubmed
pubmed-article:12534353pubmed:affiliationUnit of Endocrinology, Scientific Institute 'Casa Sollievo della Sofferenza', 71013 San Giovanni Rotondo, Foggia, Italy.lld:pubmed
pubmed-article:12534353pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12534353pubmed:publicationTypeClinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12534353lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12534353lld:pubmed